Prof. Dr. med. Thomas Hundsberger
chief of service
Neurologie, Medizinische Onkologie und Hämatologie · Dept. III, Dept. I
Neuroonkologie – ASCO 2013: Erst- und Rezidivbehandlung von Glioblastomen – Ernüchterung durch negative Phase-III-Studien
Hundsberger T (2013). Neuroonkologie – ASCO 2013: Erst- und Rezidivbehandlung von Glioblastomen – Ernüchterung durch negative Phase-III-Studien.
Sep 19, 2013Neuroonkologie – ASCO 2013: Erst- und Rezidivbehandlung von Glioblastomen – Ernüchterung durch negative Phase-III-Studien
Sep 19, 2013-
Hundsberger Thomas
Secondary spinal anaplastic ependymoma ten years after treatment of Hodgkin’s disease
Hochstrasser A, Hundsberger T, Siano M. Secondary spinal anaplastic ependymoma ten years after treatment of Hodgkin’s disease. Schweiz. Krebsbulletin 2013; 2:175-178.
Jun 25, 2013Secondary spinal anaplastic ependymoma ten years after treatment of Hodgkin’s disease
Jun 25, 2013Schweiz. Krebsbulletin 2013; 2:175-178
Hochstrasser Andreas, Hundsberger Thomas, Siano Marco
Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease
Hundsberger T, Rohrbach M, Kern L, Rösler K. Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease. J Neurol 2013; 260:2279-2285.
Jun 8, 2013Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease
Jun 8, 2013J Neurol 2013; 260:2279-2285
Hundsberger Thomas, Rohrbach Marianne, Kern Lukas, Rösler Kai M
EBV-assoziiertes, primäres B-Zell-Non-Hodgkin-Lymphom des ZNS (PCNSL) nach Lebertrans-plantation
Müller-Westermann J, Hollenstein M, Hundsberger T, Tettenborn B (2013). EBV-assoziiertes, primäres B-Zell-Non-Hodgkin-Lymphom des ZNS (PCNSL) nach Lebertrans-plantation.
Jun 8, 2013EBV-assoziiertes, primäres B-Zell-Non-Hodgkin-Lymphom des ZNS (PCNSL) nach Lebertrans-plantation
Jun 8, 201386. DGN-Jahreskongresses 2013
Müller-Westermann J, Hollenstein M, Hundsberger Thomas, Tettenborn Barbara
Zungenmyokymien- Drei Fälle, verschiedene Ätiologien
Leupold D, Schilg-Hafer L, Hundsberger T, Tettenborn B, Felbecker A (2013). Zungenmyokymien- Drei Fälle, verschiedene Ätiologien.
Jun 8, 2013Zungenmyokymien- Drei Fälle, verschiedene Ätiologien
Jun 8, 2013DGN Dresden Aktuelle Neurologie
Leupold Daniela, Schilg-Hafer Lenka, Hundsberger Thomas, Tettenborn Barbara, Felbecker Ansgar
Radiation-induced cavernoma after total body irradiation and haematopoietic stem cell transplantation in an adult patient suffering from acute myeloid leukaemia
Walch J, Tettenborn B, Weber J, Hundsberger T. Radiation-induced cavernoma after total body irradiation and haematopoietic stem cell transplantation in an adult patient suffering from acute myeloid leukaemia. Case Rep Neurol 2013; 5:91-7.
Apr 18, 2013Radiation-induced cavernoma after total body irradiation and haematopoietic stem cell transplantation in an adult patient suffering from acute myeloid leukaemia
Apr 18, 2013Case Rep Neurol 2013; 5:91-7
Walch Julia, Tettenborn Barbara, Weber Johannes, Hundsberger Thomas
Radiation-induced cavernoma after total body irradiation and haematopoietic stem cell transplantation in an adult patient suffering from acute myeloid leukaemia
Hundsberger T, Weber J, Tettenborn B, Walch J. Radiation-induced cavernoma after total body irradiation and haematopoietic stem cell transplantation in an adult patient suffering from acute myeloid leukaemia. Case Reports in Neurology 2013; 5:91-97.
Apr 18, 2013Radiation-induced cavernoma after total body irradiation and haematopoietic stem cell transplantation in an adult patient suffering from acute myeloid leukaemia
Apr 18, 2013Case Reports in Neurology 2013; 5:91-97
Hundsberger Thomas, Weber Johannes, Tettenborn Barbara, Walch Julia
Management der Von Hippel-Lindau Erkrankung
Hundsberger T. Management der Von Hippel-Lindau Erkrankung - Eine interdisziplinäre Herausforderung. info@onkologie 2013; 04:24-28.
Feb 9, 2013Management der Von Hippel-Lindau Erkrankung
Feb 9, 2013info@onkologie 2013; 04:24-28
Hundsberger Thomas
Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas
Hundsberger T, Brügge D, Putora P, Weder P, Weber J, Plasswilm L. Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas. J Neurooncol 2013; 112:133-9.
Jan 12, 2013Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas
Jan 12, 2013J Neurooncol 2013; 112:133-9
Hundsberger Thomas, Brügge Detlef, Putora Paul Martin, Weder Patrik, Weber Johannes, Plasswilm Ludwig
Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomas
Seystahl K, Wiestler B, Hundsberger T, Happold C, Wick W, Weller M, Wick A. Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomas. Eur Neurol 2012; 69:95-101.
Nov 22, 2012Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomas
Nov 22, 2012Eur Neurol 2012; 69:95-101
Seystahl Katharina, Wiestler Benedikt, Hundsberger Thomas, Happold Caroline, Wick Wolfgang, Weller Michael, Wick Antje
Unilateral myokymia of the tongue – two cases, different aetiologies
Leupold D, Felbecker A, Tettenborn B, Hundsberger T (2012). Unilateral myokymia of the tongue – two cases, different aetiologies.
Nov 8, 2012Unilateral myokymia of the tongue – two cases, different aetiologies
Nov 8, 2012SNG Tagung
Leupold Daniela, Felbecker Ansgar, Tettenborn Barbara, Hundsberger Thomas
Case Report of a patient with LGL-Leukemia who Developed a Leptomeningeal Lymphomatosis
Schallegger K, Brügge D, Hitz F, Hundsberger T, Cathomas R, Plasswilm L (2012). Case Report of a patient with LGL-Leukemia who Developed a Leptomeningeal Lymphomatosis.
Apr 19, 2012Case Report of a patient with LGL-Leukemia who Developed a Leptomeningeal Lymphomatosis
Apr 19, 2012SASRO 2012
Schallegger K, Brügge Detlef, Hitz Felicitas, Hundsberger Thomas, Cathomas R, Plasswilm Ludwig
Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial
Korfel A, Birnbaum T, Kirchen H, Mergenthaler H, Schubert J, Berdel W, Birkmann J, Hummel M, Thiel E, Leithäuser M, Hundsberger T, Weller M, Martus P, Roth P, Klasen H, Roeth A, Rauch M, Hertenstein B, Fischer T, Fischer L. Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial. Ann Oncol 2012; 23:2374-2380.
Mar 5, 2012Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial
Mar 5, 2012Ann Oncol 2012; 23:2374-2380
Korfel A, Birnbaum T, Kirchen H, Mergenthaler H-G, Schubert J, Berdel W, Birkmann J, Hummel M, Thiel E, Leithäuser M, Hundsberger Thomas, Weller M, Martus P, Roth P, Klasen H A, Roeth A, Rauch M, Hertenstein B, Fischer T, Fischer L
F-18 choline PET does not detect increased metabolism in F-18 fluoroethyltyrosine-negative low-grade gliomas
Roelcke U, Bruehlmeier M, Hefti M, Hundsberger T, Nitzsche E. F-18 choline PET does not detect increased metabolism in F-18 fluoroethyltyrosine-negative low-grade gliomas. Clin Nucl Med 2012; 37:e1-3.
Jan 26, 2012F-18 choline PET does not detect increased metabolism in F-18 fluoroethyltyrosine-negative low-grade gliomas
Jan 26, 2012Clin Nucl Med 2012; 37:e1-3
Roelcke Ulrich, Bruehlmeier Matthias, Hefti Martin, Hundsberger Thomas, Nitzsche Egbert U
Aktuelle Therapie des Glioblastoms
Hundsberger T. Aktuelle Therapie des Glioblastoms - Noch immer sehr schlechte Prognose. info@onkologie 2011; 06:18-20.
Dec 30, 2011Aktuelle Therapie des Glioblastoms
Dec 30, 2011info@onkologie 2011; 06:18-20
Hundsberger Thomas
Radiation-Induced De Novo-Cavernoma after Treatment of Acute Myeloid Leukaemia
Walch J, Weber J, Tettenborn B, Hundsberger T (2011). Radiation-Induced De Novo-Cavernoma after Treatment of Acute Myeloid Leukaemia.
Nov 8, 2011Radiation-Induced De Novo-Cavernoma after Treatment of Acute Myeloid Leukaemia
Nov 8, 2011186. SNG Jahrestagung, 2011
Walch J, Weber J, Tettenborn Barbara, Hundsberger Thomas
Intravascular lymphoma mimicking cerebral stroke: report of two cases
Hundsberger T, Tettenborn B, von Moos R, Fournier J, Anliker M, Gähler A, Fretz C, Kleger G, Cogliatti S, Driessen C. Intravascular lymphoma mimicking cerebral stroke: report of two cases. Case Rep Neurol 2011; 3:278-283.
Oct 24, 2011Intravascular lymphoma mimicking cerebral stroke: report of two cases
Oct 24, 2011Case Rep Neurol 2011; 3:278-283
Hundsberger Thomas, Tettenborn Barbara, von Moos Roger, Fournier Jean-Yves, Anliker Mark, Gähler Anita, Fretz Christian, Kleger Gian-Reto, Cogliatti Sergio B., Driessen Christoph
Evaluation of the autonomic nervous system in patients with stage IV incurable, advanced solid tumours
Hundsberger T, Vehoff J, Hägele-Link S, Tettenborn B, Strasser F (2011). Evaluation of the autonomic nervous system in patients with stage IV incurable, advanced solid tumours.
Oct 12, 2011Evaluation of the autonomic nervous system in patients with stage IV incurable, advanced solid tumours
Oct 12, 201113th annual meeting of the European federation of autonomic societies EFAS
Hundsberger Thomas, Vehoff Jochen, Hägele-Link Stefan, Tettenborn Barbara, Strasser F.
Akute Wernicke-Enzephalopathie im Rahmen biliär bedingter rezidivierender Pankreatitiden-ein Fallbericht
Müller-Westermann J, Traichel B, Hundsberger T, Eychmuller S, Tettenborn B (2011). Akute Wernicke-Enzephalopathie im Rahmen biliär bedingter rezidivierender Pankreatitiden-ein Fallbericht.
Sep 8, 2011Akute Wernicke-Enzephalopathie im Rahmen biliär bedingter rezidivierender Pankreatitiden-ein Fallbericht
Sep 8, 201184. DGN (Deutsche Gesellschaft für Neurologie) Jahreskongress, 2011
Müller-Westermann J, Traichel B, Hundsberger Thomas, Eychmuller S, Tettenborn Barbara
Die Problematik der Enzymersatztherapie beim Morbus Pompe (Glykogenose Typ II)
Hundsberger T. Die Problematik der Enzymersatztherapie beim Morbus Pompe (Glykogenose Typ II) - Eine medizinische Einschätzung. Schweiz Med Forum 2011; 11:427-429.
Jun 22, 2011Die Problematik der Enzymersatztherapie beim Morbus Pompe (Glykogenose Typ II)
Jun 22, 2011Schweiz Med Forum 2011; 11:427-429
Hundsberger Thomas